STUB1 and metabolic dysfunction-associated steatotic liver disease: Parallel H&E analyses revealed that the microvesicular steatosis observed in 2-month-old CHIP−/−-livers (Fig. 2) had now progressed to the central macrovesicular steatosis characteristic of NAFLD/NASH livers (Fig. 7A-iv).